Impact of Endothelial and Leukocyte Senescence in Circulatory Shock States

Recruiting Observational Study
Shock Cardiovascular Diseases Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
520 (estimated)
Sponsor
University Hospital, Strasbourg, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Circulatory shocks (CS) are life-threatening, acute organ dysfunction. Advances in critical care medicine have decreased early hospital mortality, increasing the number of surviving patients. Regrettably, these survivors are at increased risk of new infections but also of cardiovascular disease. The investigators hypothesize that CS with multi-organ dysfunction is associated with premature senesc…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Circulatory shock * patient with health care insurance Exclusion criteria: * Patients' refusal to participate in clinical research * Pregnant woman * Breastfeeding woman * A patient with a protective order
Contacts

Morgane CLERC

03 88 11 68 55

morgane.clerc@chru-strasbourg.fr

CONTACT

Madoé JULIANS

03 88 11 61 86

madoe.julians@chru-strasbourg.fr

CONTACT